- My Forums
- Tiger Rant
- LSU Score Board
- LSU Recruiting
- SEC Rant
- SEC Score Board
- Saints Talk
- Pelicans Talk
- More Sports Board
- Coaching Changes
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Longer Tail Tiger
| Favorite team: | LSU |
| Location: | |
| Biography: | |
| Interests: | |
| Occupation: | |
| Number of Posts: | 379 |
| Registered on: | 12/24/2019 |
| Online Status: | Not Online |
Recent Posts
Message
ELVN a speculative biotech with a leukemia drug seemingly favored by Adam Feuerstein...
Posted by Longer Tail Tiger on 11/9/26 at 9:18 pm
ELVN might be worth looking into and doing a full and complete due diligence for any high-risk biotech investors to see if he's right or wrong.
The Company does look interesting. Below is some info from the Company's latest ER.
Twitter Link
:cheers:
Loading Twitter/X Embed...
If tweet fails to load, click here. The Company does look interesting. Below is some info from the Company's latest ER.
Twitter Link
:cheers:
re: Venture Global NYSE Release
Posted by Longer Tail Tiger on 11/4/26 at 5:26 pm to Longer Tail Tiger
VG down $1.00 today with a closing price of $12.00. Is this price a buying opportunity? Would appreciate any insights or thoughts.
re: anyone in voyager technologies (VOYG)?
Posted by Longer Tail Tiger on 10/27/26 at 5:40 pm to Longer Tail Tiger
re: anyone in voyager technologies (VOYG)?
Posted by Longer Tail Tiger on 10/27/26 at 4:50 pm to cgrand
I have some shares for an average cost of about $28.85. This morning instead of adding a few shares, I took a chance and put in an early order for some November 20 calls with a strike price of $30 for 90 cents, which filled. Being conservative, I rarely buy calls, but the last price of the calls today was $1.775. With my luck I should've sold the calls but soon will. :lol:
re: anyone in voyager technologies (VOYG)?
Posted by Longer Tail Tiger on 10/26/26 at 9:51 am to cgrand
Voyager Awarded Interstellar Lab Mission Management Contract
LINK
LINK
re: anyone in voyager technologies (VOYG)?
Posted by Longer Tail Tiger on 10/12/26 at 3:33 pm to cgrand
I have shares and am down about $1.65 per share.
re: Biotech Long Play: ABVX
Posted by Longer Tail Tiger on 10/4/26 at 6:19 pm to bayoubengals88
quote:
The reason no deal has happened yet: every potential acquirer — AbbVie, Pfizer, BMS, Sanofi — is waiting for the Crohn's disease Phase 2b data due Q4 2026.
I may be confused as to the whether the disclosure of the Crohn's Phase 2b data is due in Q4 2026 or mid-2027. However, unless there's been a more recent update of the expected disclosure date, in the SEC 6-K filed on September 21, 2026, on page 8, the following is stated: "Crohn’s disease ("CD"): Our ENHANCE-CD Phase 2b clinical trial of obefazimod in patients with CD is still ongoing, and the 12-week induction topline data read-out is expected in mid-2027." LINK
re: Spec Play - HGRAF
Posted by Longer Tail Tiger on 10/4/26 at 11:46 am to masoncj
re: Spec play KRMD KORU Medical Systems, Inc.
Posted by Longer Tail Tiger on 10/1/26 at 10:30 pm to Longer Tail Tiger
Spec play KRMD KORU Medical Systems, Inc.
Posted by Longer Tail Tiger on 9/28/26 at 3:49 pm
KRMD as a spec play seems interesting and might be worthy of being placed on a watch list.
Per Zacks Investment research,
Closed today at $3.06. Per TipRanks, it's covered by 5 analysts, high target price of $8 and low target of $5, with a consensus target price of $6.30. FWIW, Zacks rates it a 2, i.e. a Buy.
Here's a link to KRMD's Second Quarter 2026 Results and Updates Full Year 2026 Guidance: LINK
And here's a link to a transcript of the 2026 Second Quarter conference call: LINK
ETA: FWIW, on September 8, 2026, the CEO bought 32,000 shares @ a price of $3.16 per share. LINK
And on June 11, 2026, he bought 5,000 shares @ a price of $3.96 and 7,500 shares @ a price of $3.93 per share. LINK
Per Zacks Investment research,
quote:
KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J.
Closed today at $3.06. Per TipRanks, it's covered by 5 analysts, high target price of $8 and low target of $5, with a consensus target price of $6.30. FWIW, Zacks rates it a 2, i.e. a Buy.
Here's a link to KRMD's Second Quarter 2026 Results and Updates Full Year 2026 Guidance: LINK
And here's a link to a transcript of the 2026 Second Quarter conference call: LINK
ETA: FWIW, on September 8, 2026, the CEO bought 32,000 shares @ a price of $3.16 per share. LINK
And on June 11, 2026, he bought 5,000 shares @ a price of $3.96 and 7,500 shares @ a price of $3.93 per share. LINK
re: Venture Global NYSE Release
Posted by Longer Tail Tiger on 9/27/26 at 7:52 am to DiamondDog
LINK :cheers:
re: Spec Play - HGRAF
Posted by Longer Tail Tiger on 9/26/26 at 3:03 pm to Neauxla
My shares were bought in a Schwab cash account, and I received an email this morning titled: "Vote now! HYDROGRAPH CLEAN POWER INC. Special Meeting".
I voted as recommended by HGRAF's management on all the propositions. :cheers:
ETA: the title of the email.
I voted as recommended by HGRAF's management on all the propositions. :cheers:
ETA: the title of the email.
re: Spec Play - HGRAF
Posted by Longer Tail Tiger on 9/26/26 at 2:17 pm to jevins_slickin
I too voted my shares. I did it this morning. :cheers:
re: Venture Global NYSE Release
Posted by Longer Tail Tiger on 9/24/26 at 8:12 pm to DiamondDog
Are any of y'all still invested in, buying, holding, or trading VG or have it on a watch list? :cheers:
re: Spec Play - HGRAF
Posted by Longer Tail Tiger on 9/13/26 at 10:15 pm to MrLSU
The information I posted from Grok AI is not my information. That's, of course, why it's in quotation marks. The quote is easy to understand. In my opinion, it doesn't disparage the views you originally expressed; and in fact it praises the two law firms you mentioned. I posted it soley to share the views in the quote from Grok.
I do own shares; and, at this point, I'm continuing to hold my shares.
But, I'm not a financial advisor; and I only suggest that other shareholders rely solely on their own due diligence in making their decisions to buy, hold, sell, or short HGRAF shares.
All the best to you and all other HGRAF shareholders! :cheers:
I do own shares; and, at this point, I'm continuing to hold my shares.
But, I'm not a financial advisor; and I only suggest that other shareholders rely solely on their own due diligence in making their decisions to buy, hold, sell, or short HGRAF shares.
All the best to you and all other HGRAF shareholders! :cheers:
re: Spec Play - HGRAF
Posted by Longer Tail Tiger on 9/12/26 at 11:04 pm to MrLSU
Per Grok AI re the named law firms:
"HydroGraph already has Canadian securities/corporate counsel experience on its board (e.g., a partner at a Toronto firm with relevant public-company and arrangement experience) and is working with established Canadian market participants (e.g., Canaccord as underwriter on recent financings). Adding or using competent U.S. counsel for the redomicile is standard and sufficient. In short, the named firms are excellent options if selected, but they are not a prerequisite. Another competent U.S. firm (or team) with the right cross-border public-company reorganization experience can handle the redomicile equally well—or better on cost, responsiveness, or fit with Hydrograph’s specific needs and Texas focus. The eventual choice of counsel will be a business decision by the company, not a legal requirement for the transaction to succeed. " [bolding added for emphasis]
"HydroGraph already has Canadian securities/corporate counsel experience on its board (e.g., a partner at a Toronto firm with relevant public-company and arrangement experience) and is working with established Canadian market participants (e.g., Canaccord as underwriter on recent financings). Adding or using competent U.S. counsel for the redomicile is standard and sufficient. In short, the named firms are excellent options if selected, but they are not a prerequisite. Another competent U.S. firm (or team) with the right cross-border public-company reorganization experience can handle the redomicile equally well—or better on cost, responsiveness, or fit with Hydrograph’s specific needs and Texas focus. The eventual choice of counsel will be a business decision by the company, not a legal requirement for the transaction to succeed. " [bolding added for emphasis]
re: Spec Play - HGRAF
Posted by Longer Tail Tiger on 9/11/26 at 8:10 am to MrLSU
Per Kevin Bambrough linked below:
LINK
quote:
What blows my mind and isn’t spoken about enough is that
$hg
$hgraf graphene doesn’t just reduce the amount of polymers needed to make plastics by 30%. It allows them to be recycled likely 9 times vs 6 times. That math is extremely exciting…
LINK
re: Spec Play - HGRAF
Posted by Longer Tail Tiger on 9/4/26 at 12:37 am to Jax-Tiger
I'm done adding shares too but added some earlier this week. Never allowed lending of any shares in my account and never used margin and never will. Hope it works out well for all of us! :cheers:
re: Paging BB88: got a couple Monday morning duckies I need to spend.
Posted by Longer Tail Tiger on 8/31/26 at 9:32 pm to ynlvr
Popular
0











